Multiple SkleroseMS Behandlung

2020

Bertolotto A, Arroyo R, Celius EG, Comi G, Havrdova EK, Honeycutt WD, Hunter SF, Izquierdo G, Kornek B, Miller T, Mitsikostas DD, Singer BA, Ziemssen T, Chung L, Daizadeh N, Afsar S, Hashemi L, Senior P.

Neurol Ther. 2020 Dec;9(2):443-457.

Multiple SkleroseMS Behandlung

2020

Moser T, Schwenker K, Seiberl M, Feige J, Akgün K, Haschke-Becher E, Ziemssen T, Sellner J.

Ann Clin Transl Neurol. 2020 Nov;7(11):2199-2212.

Multiple SkleroseMS Behandlung

2020

Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Ziemssen T, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups.

N Engl J Med. 2020 Aug 6;383(6):546-557.

Multiple SkleroseMS Behandlung

2019

Mäurer M, Tiel-Wilck K, Oehm E, Richter N, Springer M, Oschmann P, Manzel A, Hieke-Schulz S, Zingler V, Kandenwein JA, Ziemssen T, Linker RA.

Ther Adv Neurol Disord. 2019 Dec 19;12:1756286419892077.

Multiple SkleroseMS Behandlung

2019

Hobart J, Ziemssen T, Feys P, Linnebank M, Goodman AD, Farrell R, Hupperts R, Blight AR, Englishby V, McNeill M, Chang I, Lima G, Elkins J; ENHANCE study investigators.

CNS Drugs. 2019 Jan;33(1):61-79.

Multiple SkleroseMS Behandlung

2019

Barclay K, Carruthers R, Traboulsee A, Bass AD, LaGanke C, Bertolotto A, Boster A, Celius EG, de Seze J, Cruz DD, Habek M, Lee JM, Limmroth V, Meuth SG, Oreja-Guevara C, Pagnotta P, Vos C, Ziemssen T, Baker DP, Wijmeersch BV.

Front Neurol. 2019 Mar 22;10:253.

Multiple SkleroseMS Behandlung

2019

Ziemssen T.

Neurodegener Dis Manag 2019;9(2):1-2

Multiple SkleroseMS Behandlung

2019

Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Couto CA, Findlay JA, Cornelissen C; PANGAEA study group.

Neurol Neuroimmunol Neuroinflamm. 2019 Mar 7;6(3):e548.